Document is current
Any future updates will be listed below
-
Authors
Hu, Jie http://orcid.org/0000-0003-2940-6525
McMillan, Sara S http://orcid.org/0000-0003-3427-4467
Theodoros, Theo http://orcid.org/0000-0003-0421-6397
Collins, Jack C http://orcid.org/0000-0002-0266-5394
El-Den, Sarira http://orcid.org/0000-0001-7500-3351
O’Reilly, Claire L http://orcid.org/0000-0001-6416-8150
Wheeler, Amanda J http://orcid.org/0000-0001-9755-674X
- License Information
-
More Information
Article History
Received: 7 June 2022
Accepted: 19 October 2022
First Online: 15 November 2022
Declarations
:
: De-identified data used in this study were collected from the <i>PharMIbridge</i> RCT, which was performed in line with the principles of the Declaration of Helsinki. Ethics approval was granted by the Griffith University Human Research Ethics Committee (HREC/2019/473). The <i>PharMIbridge</i> RCT is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR12620000577910). Participation was voluntary, and all participants provided written informed consent.
: Not applicable.
: The authors declare no conflicts of interest.
